Treatment of Acute Liver Failure in Mice by Hepatocyte Xenotransplantation

Liver diseases still have a high mortality even though liver transplantation has become a standard treatment. Currently, hepatocyte transplantation has been proposed as another promising strategy. One limitation is the availability of human livers as a source of hepatocytes. Because of an unlimited...

Full description

Bibliographic Details
Main Authors: Tsuyoshi Yamamoto, Nalú Navarro-Alvarez, Alejandro Soto-Gutierrez, Takeshi Yuasa, Masaya Iwamuro, Yasuhiro Kubota, Masayuki Seita, Hironobu Kawamoto, Shahid M. Javed, Eisaku Kondo, Hirofumi Noguchi, Satoru Kobayashi M.D., Ph.D., Shuhei Nakaji, Naoya Kobayashi
Format: Article
Language:English
Published: SAGE Publishing 2010-06-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368910X508915
id doaj-952eb11be60848a2ba14efca2217eceb
record_format Article
spelling doaj-952eb11be60848a2ba14efca2217eceb2020-11-25T03:13:56ZengSAGE PublishingCell Transplantation0963-68971555-38922010-06-011910.3727/096368910X508915Treatment of Acute Liver Failure in Mice by Hepatocyte XenotransplantationTsuyoshi Yamamoto0Nalú Navarro-Alvarez1Alejandro Soto-Gutierrez2Takeshi Yuasa3Masaya Iwamuro4Yasuhiro Kubota5Masayuki Seita6Hironobu Kawamoto7Shahid M. Javed8Eisaku Kondo9Hirofumi Noguchi10Satoru Kobayashi M.D., Ph.D.11Shuhei Nakaji12Naoya Kobayashi13Department of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanBaylor Research Institute, Islet Cell Transplantation Laboratory, Baylor Institution for Immunology Research, Dallas, TX, USA3-DMatrix, Ltd., Tokyo, JapanDepartment of Biomedical Engineering, School of Engineering, Okayama University of Science, Okayama, JapanDepartment of Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, JapanLiver diseases still have a high mortality even though liver transplantation has become a standard treatment. Currently, hepatocyte transplantation has been proposed as another promising strategy. One limitation is the availability of human livers as a source of hepatocytes. Because of an unlimited supply, the use of porcine hepatocytes might address this problem. Regardless of the source, once isolated hepatocytes lose specific functionality due to the loss of the natural microenvironment. For this reason, we tested the ability of a self-assembling peptide nanofiber (SAPNF) to provide a provisional three-dimensional (3D) support to interact with cells to control their function in vivo. Isolated porcine hepatocytes were embedded in SAPNF, or collagen type I and transplanted by direct injection into the splenic pulp of SCID mice suffering from acute liver failure (ALF) by 90% hepatectomy. SAPNF porcine hepatocyte transplantation produced engraftment that was far superior to that obtained using collagen and prolonged the survival of mice with ALF, in contrast with controls. An ultrastructural evaluation using transmission electron microscopy indicated extensive cell–cell communication and preservation of hepatocyte architecture. The transplanted SAPNF hepatocytes showed higher expression of albumin and PAS and lower apoptotic events assessed by TUNEL staining. Hepatocytes culture in a truly 3D network allows in vivo maintaining of differentiated functions, and once transplanted between widely divergent species can function to correct acute liver failure in mice and prolong their survival.https://doi.org/10.3727/096368910X508915
collection DOAJ
language English
format Article
sources DOAJ
author Tsuyoshi Yamamoto
Nalú Navarro-Alvarez
Alejandro Soto-Gutierrez
Takeshi Yuasa
Masaya Iwamuro
Yasuhiro Kubota
Masayuki Seita
Hironobu Kawamoto
Shahid M. Javed
Eisaku Kondo
Hirofumi Noguchi
Satoru Kobayashi M.D., Ph.D.
Shuhei Nakaji
Naoya Kobayashi
spellingShingle Tsuyoshi Yamamoto
Nalú Navarro-Alvarez
Alejandro Soto-Gutierrez
Takeshi Yuasa
Masaya Iwamuro
Yasuhiro Kubota
Masayuki Seita
Hironobu Kawamoto
Shahid M. Javed
Eisaku Kondo
Hirofumi Noguchi
Satoru Kobayashi M.D., Ph.D.
Shuhei Nakaji
Naoya Kobayashi
Treatment of Acute Liver Failure in Mice by Hepatocyte Xenotransplantation
Cell Transplantation
author_facet Tsuyoshi Yamamoto
Nalú Navarro-Alvarez
Alejandro Soto-Gutierrez
Takeshi Yuasa
Masaya Iwamuro
Yasuhiro Kubota
Masayuki Seita
Hironobu Kawamoto
Shahid M. Javed
Eisaku Kondo
Hirofumi Noguchi
Satoru Kobayashi M.D., Ph.D.
Shuhei Nakaji
Naoya Kobayashi
author_sort Tsuyoshi Yamamoto
title Treatment of Acute Liver Failure in Mice by Hepatocyte Xenotransplantation
title_short Treatment of Acute Liver Failure in Mice by Hepatocyte Xenotransplantation
title_full Treatment of Acute Liver Failure in Mice by Hepatocyte Xenotransplantation
title_fullStr Treatment of Acute Liver Failure in Mice by Hepatocyte Xenotransplantation
title_full_unstemmed Treatment of Acute Liver Failure in Mice by Hepatocyte Xenotransplantation
title_sort treatment of acute liver failure in mice by hepatocyte xenotransplantation
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2010-06-01
description Liver diseases still have a high mortality even though liver transplantation has become a standard treatment. Currently, hepatocyte transplantation has been proposed as another promising strategy. One limitation is the availability of human livers as a source of hepatocytes. Because of an unlimited supply, the use of porcine hepatocytes might address this problem. Regardless of the source, once isolated hepatocytes lose specific functionality due to the loss of the natural microenvironment. For this reason, we tested the ability of a self-assembling peptide nanofiber (SAPNF) to provide a provisional three-dimensional (3D) support to interact with cells to control their function in vivo. Isolated porcine hepatocytes were embedded in SAPNF, or collagen type I and transplanted by direct injection into the splenic pulp of SCID mice suffering from acute liver failure (ALF) by 90% hepatectomy. SAPNF porcine hepatocyte transplantation produced engraftment that was far superior to that obtained using collagen and prolonged the survival of mice with ALF, in contrast with controls. An ultrastructural evaluation using transmission electron microscopy indicated extensive cell–cell communication and preservation of hepatocyte architecture. The transplanted SAPNF hepatocytes showed higher expression of albumin and PAS and lower apoptotic events assessed by TUNEL staining. Hepatocytes culture in a truly 3D network allows in vivo maintaining of differentiated functions, and once transplanted between widely divergent species can function to correct acute liver failure in mice and prolong their survival.
url https://doi.org/10.3727/096368910X508915
work_keys_str_mv AT tsuyoshiyamamoto treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT nalunavarroalvarez treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT alejandrosotogutierrez treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT takeshiyuasa treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT masayaiwamuro treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT yasuhirokubota treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT masayukiseita treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT hironobukawamoto treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT shahidmjaved treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT eisakukondo treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT hirofuminoguchi treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT satorukobayashimdphd treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT shuheinakaji treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
AT naoyakobayashi treatmentofacuteliverfailureinmicebyhepatocytexenotransplantation
_version_ 1724645714224480256